a) Genetic female |
a) Has any breast disease considered to be pre-malignant in 1 or both breasts, a history of breast cancer, or an untreated cancer of any type |
f) HIV positive (based on medical history) |
b) Willingness to follow all study requirements including agreeing to attend all required follow up visits and signs the informed consent |
b) Subject lives more than 3 hours travel from the treating surgeon |
g) Has been diagnosed with BIA-ALCL |
c) Agrees to donate biospecimens to the research study which may not be returned to the subjects |
c) Has an abscess or infection |
h) Has any medical condition such as obesity (BMI > 40), diabetes, chronic lung or severe cardiovascular disease that might result in unduly high surgical risk, and/or significant postoperative complications |
d) Age 30-65 |
d) Is pregnant or nursing or has had a full-term pregnancy or lactated within 3 months of enrollment |
i) Has been implanted with any device that has not been approved by the FDA or equivalent regulatory agency outside the US |
|
e) Has been implanted with any implantable medical device or silicone implant other than breast implants (except intraocular lenses) |
j) Works for any breast implant manufacturer or any of their subsidiaries, the study surgeon, or are directly related to anyone that works for a breast implant manufacturer or any of their subsidiaries |